Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Kidney International
|
September 14, 2020
Mineral bone disease in autosomal dominant polycystic kidney disease
Berenice Gitomer, Renata Pereira, Isidro B Salusky, et al.
American Journal of Nephrology
|
August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Michael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Pharmacotherapy
|
September 10, 2014
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide
Mariellen J Moore, Yan Gong, Wei Hou, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 15, 2020
Advancing Nephrology: Division Leaders Advise ASN
Gregory L Braden, Arlene Chapman, David H Ellison, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
February 21, 2017
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol
Liming Weng, Yan Gong, Jeffrey Culver, et al.
Circulation. Cardiovascular Genetics
|
March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?
Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Plos One
|
May 27, 2021
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
Patrizia Natale, Elyssa Hannan, Bénédicte Sautenet, et al.
Kidney International Reports
|
February 24, 2025
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD
Rosanna Cazzolli, Angela Ju, Patrizia Natale, et al.
Trials
|
November 25, 2017
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease
Yeoungjee Cho, Benedicte Sautenet, Gopala Rangan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pharmacology
|
May 16, 2019
β<sub>2</sub> -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies
Mohamed H Shahin, Nihal El Rouby, Daniela J Conrado, et al.
Kidney International
|
September 14, 2020
Mineral bone disease in autosomal dominant polycystic kidney disease
Berenice Gitomer, Renata Pereira, Isidro B Salusky, et al.
American Journal of Nephrology
|
August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions
Michael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Pharmacotherapy
|
September 10, 2014
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide
Mariellen J Moore, Yan Gong, Wei Hou, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 15, 2020
Advancing Nephrology: Division Leaders Advise ASN
Gregory L Braden, Arlene Chapman, David H Ellison, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
February 21, 2017
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol
Liming Weng, Yan Gong, Jeffrey Culver, et al.
Circulation. Cardiovascular Genetics
|
March 15, 2014
Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose?
Rhonda M Cooper-Dehoff, Wei Hou, Liming Weng, et al.
Plos One
|
May 27, 2021
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review
Patrizia Natale, Elyssa Hannan, Bénédicte Sautenet, et al.
Kidney International Reports
|
February 24, 2025
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD
Rosanna Cazzolli, Angela Ju, Patrizia Natale, et al.
Trials
|
November 25, 2017
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease
Yeoungjee Cho, Benedicte Sautenet, Gopala Rangan, et al.
Page
of 5